Advertisement

Topics

J&J Growth Plans Heavy On Line Extensions, Sticking With Immunology And Oncology

16:05 EDT 14 Sep 2018 | SCRIP

Recent launches Tremfya and Erleada are viewed at catalysts for continuing growth, along with ambitious plans to add indications for...

      

Related Stories

 

Original Article: J&J Growth Plans Heavy On Line Extensions, Sticking With Immunology And Oncology

NEXT ARTICLE

More From BioPortfolio on "J&J Growth Plans Heavy On Line Extensions, Sticking With Immunology And Oncology"

Advertisement
Quick Search
Advertisement
Advertisement